The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Cellular Transformation and Malignancy Induced by ras Require c-jun
Open accessAbstract
ras is an important oncogene in experimental animals and humans. In addition, activated ras proteins are potent inducers of the transcription factor AP-1, which is composed of heterodimeric complexes of Fos and Jun proteins. Together with the fact that deregulated expression of some AP-1 proteins can cause neoplastic transformation, this finding suggests that AP-1 may function as a critical ras effector. We have tested this hypothesis directly by analyzing the response to activated ras in cells that harbor a null mutation in the c-jun gene. The transcriptional response of AP-1-responsive genes to activated ras is severely impaired in c-jun null fibroblasts. Compared with wild-type cells, the c-jun null cells lack many characteristics of ras transformation, including loss of contact inhibition, anchorage independence, and tumorigenicity in nude mice; these properties are restored by forced expression of c-jun. Rare tumorigenic variants of ras-expressing c-jun null fibroblasts do arise. Analysis of these variants reveals a consistent restoration of AP-1 activity. The results provide genetic evidence that c-jun is a crucial effector for transformation by activated ras proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,616
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Angel, P. E., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P. A., & Karin, M. (1987) · Cell · doi:10.1016/0092-8674(87)90611-8 · Cited by 2,930
Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNA
Auffray, C., & Rougeon, F. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06030.x · Cited by 2,626
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P. T., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,601
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,337
Morgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,099
Cowley, S. A. (1994) · Cell · doi:10.1016/0092-8674(94)90133-3 · Cited by 1,959
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Research works printed but not linked: 2
- 10.1128/mcb.11.12.6286-6295.1991 · DOI
- 10.1128/mcb.14.11.7483-7491.1994 · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 281
Pruitt, K., Pruitt, W. M., Bilter, G. K., Westwick, J. K., & Der, C. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203964200 · Cited by 83
JunB inhibits proliferation and transformation in B-lymphoid cells
Szremska, A., Kenner, L., Weisz, E., Ott, R. G., Passegue, E. A., Artwohl, M., Freissmuth, M., Stoxreiter, R., Theussl, H., Parzer, S. B., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0915 · Cited by 86
Wang, J., Kuiatse, I., Lee, A. V., Pan, J., Giuliano, A. E., & Cui, X. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0221 · Cited by 81
de Ruiter, N. D., Wolthuis, R. M. F., van Dam, H., Burgering, B. M. T., & Bos, J. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8480-8488.2000 · Cited by 80
Ritchie, K. J., Henderson, C. J., Wang, X. J., Vassieva, O., Carrie, D., Farmer, P. B., Gaskell, M., Park, K., & Wolf, C. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1764 · Cited by 79
Xiao, L., & Lang, W. (2000) · PubMed · Cited by 77
c-Jun NH2-Terminal Kinase 2α2 Promotes the Tumorigenicity of Human Glioblastoma Cells
Cui, J., Han, S., Wang, C., Su, W., Harshyne, L. A., Holgado-Madruga, M., & Wong, A. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0136 · Cited by 75
MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression
Wang, D., Yang, W., Du, J., Devalaraja, M. N., Liang, P., Matsumoto, K., Tsubakimoto, K., Endo, T., & Richmond, A. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203820 · Cited by 74
Mack, F. A., Patel, J. H., Biju, M. P., Haase, V. H., & Simon, M. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4565-4578.2005 · Cited by 74
Cell Fate Determination Factor DACH1 Inhibits c-Jun–induced Contact-independent Growth
Wu, K., Liu, M., Li, A., Donninger, H., Rao, M., Jiao, X., Lisanti, M. P., Cvekl, A., Birrer, M. J., & Pestell, R. G. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-09-0793 · Cited by 74
Shuman, J. D., Sebastian, T. B., Kaldis, P., Copeland, T. D., Zhu, S., Smart, R. C., & Johnson, P. F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7380-7391.2004 · Cited by 73
Zhong, X., Zheng, L., Shen, J., Zhang, D., Xiong, M., Zhang, Y., He, X., Tanyi, J. L., Yang, F., Montone, K. T., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00079-16 · Cited by 73
A TAD Further: Exogenous Control of Gene Activation
Mapp, A. K., & Ansari, A. Z. (2007) · ACS Chemical Biology · doi:10.1021/cb600463w · Cited by 72
Foltz, I. N., & Schrader, J. W. (1997) · Blood · doi:10.1182/blood.v89.9.3092 · Cited by 72
NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis
Jo, H., Zhang, R., Zhang, H., McKinsey, T. A., Shao, J., Beauchamp, R. D., Ballard, D. W., & Liang, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203392 · Cited by 70
Kayahara, M., Wang, X., & Tournier, C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3784-3792.2005 · Cited by 70
Johnston, I., Spence, H. J., Winnie, J. N., McGarry, L., Vass, J. K., Meagher, L., Stapleton, G., & Ozanne, B. W. (2000) · Oncogene · doi:10.1038/sj.onc.1203927 · Cited by 69
Qi, X.-M., Tang, J., Pramanik, R., Schultz, R. M., Shirasawa, S., Sasazuki, T., Han, J., & Chen, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313964200 · Cited by 68
Essential Role of p38γ in K-Ras Transformation Independent of Phosphorylation
Tang, J., Qi, X.-M., Mercola, D., Han, J., & Chen, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500699200 · Cited by 68
García‐Tuñón, I., Ricote, M., Ruiz, A., Fraile, B., Paniagua, R., & Royuela, M. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00277.x · Cited by 68
Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model
Zhang, Y., Pu, X., Shi, M., Chen, L., Song, Y., Lu, Q., Yuan, G., Zhang, H., Yu, M., Hu, M., et al. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-145 · Cited by 68
Molecular signals in anti-apoptotic survival pathways
O'Gorman, D., & Cotter, T. G. (2001) · Leukemia · doi:10.1038/sj.leu.2401998 · Cited by 69
Turner, S. D., Tooze, R. M., MacLennan, K., & Alexander, D. R. (2003) · Oncogene · doi:10.1038/sj.onc.1207048 · Cited by 67
Cell context reveals a dual role for Maf in oncogenesis
Pouponnot, C., Sii-Felice, K., Hmitou, I., Rocques, N., Lecoin, L., Druillennec, S., Felder‐Schmittbuhl, M., & Eychène, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209171 · Cited by 66
Vasudevan, K. M., Burikhanov, R., Goswami, A., & Rangnekar, V. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1827 · Cited by 65
Qi, X.-M., Pohl, N. M., Loesch, M., Hou, S., Li, R., Qin, J., Cuenda, A., & Chen, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703857200 · Cited by 65
Hartkamp, J., Troppmair, J., & Rapp, U. R. (1999) · PubMed · Cited by 63
c-Jun Supports Ribosomal RNA Processing and Nucleolar Localization of RNA Helicase DDX21
Holmström, T. H., Mialon, A., Kallio, M. J., Nymalm, Y., Mannermaa, L., Holm, T., Johansson, H. J., Black, E. J., Gillespie, D. A., Salminen, T. A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709613200 · Cited by 62
Cripe, L. D., Gelfanov, V. M., Smith, E., Spigel, D., Phillips, C., Gabig, T. G., Jung, S.-H., Daggy, J., Hartman, A. D., Kneebone, P. H., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402457 · Cited by 62
Janulis, M., Silberman, S., Ambegaokar, A., Gutkind, J. S., & Schultz, R. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.801 · Cited by 61
Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase
Wong, B. C., JIANG, X. H., Lin, M. C. M., Tu, S. P., Cui, J. T., Jiang, S. H., Wong, W. M., Yuen, M., Lam, S. K., & Kung, H. F. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.10.063 · Cited by 60
Hu, Y.-F., & Li, R. (2002) · Genes & Development · doi:10.1101/gad.995502 · Cited by 60
Lu, H., Li, J., Zhang, D., Stoner, G. D., & Huang, C. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5401_8 · Cited by 59
FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders
Chiappetta, G., Ferraro, A., Botti, G., Monaco, M., Pasquinelli, R., Vuttariello, E., Arnaldi, L. A. T., Bonito, M. D., D’Aiuto, G., Pierantoni, G. M., et al. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-17 · Cited by 56
Mialon, A., Sankinen, M., Söderström, H., Junttila, T. T., Holmström, T. H., Koivusalo, R., Papageorgiou, A. C., Johnson, R. S., Hietanen, S., Elenius, K., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.5040-5051.2005 · Cited by 55
Self-citationBader, A. G., Schneider, M. L., Bister, K., & Hartl, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204938 · Cited by 54
Transcriptional coactivation of c-Jun by the KSHV-encoded LANA
An, J., Sun, Y., & Rettig, M. B. (2003) · Blood · doi:10.1182/blood-2003-05-1538 · Cited by 54
MECHANISMS OF CELL-CYCLE CHECKPOINTS: AT THE CROSSROADS OF CARCINOGENESIS AND DRUG DISCOVERY*
Flatt, P. M., & Pietenpol, J. A. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100102335 · Cited by 54
Key Effectors of Signal Transduction and G 1 Progression
Roussel, M. F. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60763-0 · Cited by 55
Bose, B., Motiwale, L., & Rao, K. V. K. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.001 · Cited by 53
ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos
Gilley, R., March, H. N., & Cook, S. J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.006 · Cited by 53
Okamura, T., Antoun, G. R., Keir, S. T., Friedman, H. S., Bigner, D. D., & Ali‐Osman, F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.656140 · Cited by 55
Dominant Negativec-junInhibits Activation of the Cyclin D1 and Cyclin E Kinase Complexes
Hennigan, R. F., & Stambrook, P. J. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2352 · Cited by 53
FRA-1 expression in hyperplastic and neoplastic thyroid diseases.
Chiappetta, G., Tallini, G., Biasio, M. C. D., Pentimalli, F., de Nigris, F., Losito, S., Fedele, M., Battista, S., Verde, P., Santoro, M., et al. (2000) · PubMed · Cited by 52
RetractedDDX21 promotes gastric cancer proliferation by regulating cell cycle
Cao, J., Wu, N., Han, Y., Hou, Q., Zhao, Y., Pan, Y., Xie, X., & Chen, F. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.060 · Cited by 50
Krp1, a novel kelch related protein that is involved in pseudopod elongation in transformed cells
Spence, H. J., Johnston, I., Ewart, K., Buchanan, S. J., FitzGerald, U., & Ozanne, B. W. (2000) · Oncogene · doi:10.1038/sj.onc.1203433 · Cited by 50
Reduced risk of apoptosis: mechanisms of stress responses
Milisav, I., Poljšak, B., & Ribarič, S. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1317-3 · Cited by 49
Molecular genetic dissection of glucocorticoid receptor function in vivo
Reichardt, H. M., Tuckermann, J. P., Bauer, A., & Schütz, G. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/s003930070001 · Cited by 49
Arginine methylation of the c‐Jun coactivator RACO‐1 is required for c‐Jun/AP‐1 activation
Davies, C. C., Chakraborty, A., Diefenbacher, M. E., Skehel, M. J., & Behrens, A. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.98 · Cited by 48
Burgess, G. S., Williamson, E. A., Cripe, L. D., Litz-Jackson, S., Bhatt, J. A., Stanley, K., Stewart, M. J., Kraft, A. S., Nakshatri, H., & Boswell, H. S. (1998) · Blood · doi:10.1182/blood.v92.7.2450 · Cited by 48
Oncogene at last—c-Jun promotes liver cancer in mice
Maeda, S., & Karin, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00025-4 · Cited by 45
Stauber, A. J., & Bull, R. J. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8159 · Cited by 45
Mathiasen, D. P., Egebjerg, C., Andersen, S. H., Rafn, B., Puustinen, P., Khanna, A., Daugaard, M., Valo, E., Tuomela, S., Bøttzauw, T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.230 · Cited by 44
Dumond, H., Danielou, N., Pinto, M., & Bolotin‐Fukuhara, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01845.x · Cited by 44
JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer
Ruiz, E. J., Lan, L., Diefenbacher, M. E., Riising, E. M., Costa, C. D., Chakraborty, A., Hoeck, J. D., Spencer‐Dene, B., Kelly, G. P., David, J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.124985 · Cited by 44
Bonovich, M. T., Olive, M., Reed, E., O'Connell, B. C., & Vinson, C. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700409 · Cited by 43
Endo180 Binds to the C-terminal Region of Type I Collagen
Thomas, E. K., Nakamura, M., Wienke, D., Isacke, C. M., Pozzi, A., & Liang, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501155200 · Cited by 43
Ghosh, S., Wu, Y., Li, R., & Hu, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208415 · Cited by 42
Stress kinase signaling in cancer: fact or fiction?
Rennefahrt, U. E. E., Janakiraman, M., Öllinger, R., & Troppmair, J. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.003 · Cited by 41
Li, J., & Smithgall, T. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13828 · Cited by 42
Nagarajan, P., Parikh, N., Garrett‐Sinha, L. A., & Sinha, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004179 · Cited by 40
Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation
Davies, C. C., Chakraborty, A., Cipriani, F., Haigh, K., Haigh, J. J., & Behrens, A. (2010) · Nature Cell Biology · doi:10.1038/ncb2098 · Cited by 40
AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene
Ameyar‐Zazoua, M., Wisniewska, M. B., Bakiri, L., Wagner, E. F., Yaniv, M., & Weitzman, J. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208424 · Cited by 42
Lipner, M. B., Peng, X. L., Jin, C., Xu, Y., Gao, Y., East, M. P., Rashid, N. U., Moffitt, R. A., Hererra, S. G., Morrison, A. B., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.129905 · Cited by 39
c-Jun Regulates Phosphoinositide-dependent Kinase 1 Transcription
Lopez‐Bergami, P., Kim, H., Dewing, A., Goydos, J. S., Aaronson, S. A., & Ronai, Z. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.075630 · Cited by 39
Pathophysiological Significance of Hepatic Apoptosis
Wang, K., & Lin, B. (2012) · ISRN Hepatology · doi:10.1155/2013/740149 · Cited by 39
Oncogenic transformation of human cells: shortcomings of rodent model systems
Akagi, T. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.001 · Cited by 38
Katabami, M., Donninger, H., Hommura, F., Leaner, V. D., Kinoshita, I., Chick, J. F. B., & Birrer, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413892200 · Cited by 38
Acute and chronic cadmium exposure promotes E‐cadherin degradation in MCF7 breast cancer cells
Ponce, E., Louie, M. C., & Sevigny, M. B. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22170 · Cited by 35
Choi, H. S., Kang, B. S., Shim, J., Cho, Y., Choi, B. Y., Bode, A. M., & Dong, Z. (2007) · The FASEB Journal · doi:10.1096/fj.07-9078com · Cited by 36
Li, Q., Qi, X.-M., Pramanik, R., Pohl, N. M., Loesch, M., & Chen, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604052200 · Cited by 34
Viral proteins that regulate cellular signalling.
Krajcsi, P., & Wold, W. S. M. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-6-1323 · Cited by 33
Ras Signaling, Deregulation of Gene Expression and Oncogenesis
Ülkü, A. S., & Der, C. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48158-8_8 · Cited by 33
Chen, G., Templeton, D. J., Suttle, D. P., & Stacey, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1203149 · Cited by 32
c-Jun N-Terminal Kinase 1 Phosphorylates Myt1 To Prevent UVA-Induced Skin Cancer
Choi, H. S., Bode, A. M., Shim, J., Lee, S., & Dong, Z. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01508-08 · Cited by 31
Görögh, T., Béress, L., Quabius, E. S., Ambrosch, P., & Hoffmann, M. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-12 · Cited by 31
Protooncogenes as mediators of apoptosis
Teng, C. S. (2000) · International review of cytology · doi:10.1016/s0074-7696(00)97004-9 · Cited by 30
Janssen, R. A., & Mier, J. W. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.5.897 · Cited by 30
Jabbour, E. J., Kantarjian, H. M., & Cortes, J. E. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190412331272677 · Cited by 30
Saenglee, S., Jogloy, S., Patanothai, A., & Senawong, T. (2016) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1601-23 · Cited by 28
Moulana, I., Priyani, A. A. H., de Silva, M. V. C., & Dassanayake, R. S. (2017) · Hormones and Cancer · doi:10.1007/s12672-017-0315-4 · Cited by 29
Walker, M. J. P., Shortridge, M. D., Albin, D., Cominsky, L. Y., & Varani, G. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.001 · Cited by 26
Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosis
Barkan, B., Cox, A. D., & Kloog, Y. (2013) · Oncotarget · doi:10.18632/oncotarget.844 · Cited by 26
Pro-Oncogenic and Anti-Oncogenic Pathways: Opportunities and Challenges of Cancer Therapy
Zhang, J., Chen, Y., & Lu, Q. (2010) · Future Oncology · doi:10.2217/fon.10.15 · Cited by 29
c-Jun NH2-Terminal Kinase 2 Is Required for Ras Transformation Independently of Activator Protein 1
Nielsen, C. W., Thastrup, J., Bøttzauw, T., Jäättelä, M., & Kallunki, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2801 · Cited by 26
Targeting DNA methyltransferase in cancer
Moshe Szyf, A. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006023023787 · Cited by 26
Kakumoto, K., Sasai, K., Sukezane, T., Oneyama, C., Ishimaru, S., Shibutani, K., Mizushima, H., Mekada, E., Hanafusa, H., & Akagi, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601222103 · Cited by 25
Yumita, W., IKEO, Y., Yamauchi, K., Sakurai, A., & Hashizume, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10885 · Cited by 25
Okan, E., Drewett, V., Shaw, P. E., & Jones, P. (2001) · Oncogene · doi:10.1038/sj.onc.1204260 · Cited by 24
Paasinen-Sohns, A., Kielosto, M., Kääriäinen, E., Eloranta, T. O., Laine, A. M., Jänne, O. A., Birrer, M. J., & Hölttä, E. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.4.801 · Cited by 24
Cancer in growth hormone excess and growth hormone deficit
Guevara‐Aguirre, J., Peña, G., Acosta, W., Pazmiño, G., Saavedra, J., Soto, L., Lescano, D., Guevara, A., & Gavilanes, A. W. D. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0402 · Cited by 24
Identification of an Alternatively Spliced RNA for the Ras Suppressor RSU-1 in Human Gliomas
Chunduru, S., Kawami, H., Gullick, R., Monacci, W. J., Dougherty, G. W., & Cutler, M. L. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1021130620178 · Cited by 23
Kielosto, M., Nummela, P., Katainen, R., Leaner, V. D., Birrer, M. J., & Hölttä, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3188-2 · Cited by 23
Tv, P., Medvedev, A. V., Kukushkin, A. N., Svetlikova, S. B., van der Eb, A. J., Dorsman, J. C., & Pospelov, V. A. (1999) · Europe PMC (PubMed Central) · Cited by 23
Skinner, M., Qu, S., Moore, C., & Wisdom, R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2372 · Cited by 23
Self-citationOncogenes as Novel Targets for Cancer Therapy (Part IV)
Zhang, Z., Li, M., Rayburn, E. R., Hill, D. L., Zhang, R., & Wang, H. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505060-00006 · Cited by 21
Expression of an oncogenic mutant Gαi2 activates Ras in Rat‐1 fibroblast cells
Edamatsu, H., Kaziro, Y., & Itoh, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01457-4 · Cited by 21
Ljungdahl, S., Linder, S. T., Franzén, B., Binétruy, B., Auer, G., & Shoshan, M. C. (1998) · PubMed · Cited by 21
Suman, S., Rachakonda, G., Mandape, S. N., Sakhare, S. S., Villalta, F., Pratap, S., Lima, M. F., & Nde, P. N. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006792 · Cited by 20
PKC412 demonstrates JNK-dependent activity against human multiple myeloma cells
Sharkey, J., Khong, T. T., & Spencer, A. G. (2006) · Blood · doi:10.1182/blood-2006-05-014092 · Cited by 20
Metadata
- Authors
- Johnson, R., Spiegelman, B., Hanahan, D., & Wisdom, R.
- Affiliations
- University of California, San Francisco (US)
- Harvard University (US)
- Vanderbilt University (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1996-08
- Volume
- 16
- Issue
- 8
- Pages
- 4504-4511
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC231449
- OpenAlex
- W1895834181
- Cited by
- 282
- References
- 61
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 7 · 2014: 4 · 2013: 8 · 2012: 2
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- c-Jun, oncogenic Ras, AP-1 transcription factor, Fos-Jun heterodimer, oncogenic transformation, anchorage-independent growth, tumorigenicity, Ras effectors
- MeSH terms
- Animals, Base Sequence, Cell Cycle, Cell Transformation, Neoplastic, Cells, Cultured, Molecular Sequence Data, Oligodeoxyribonucleotides, Genes, ras, Proto-Oncogene Proteins p21(ras), Proto-Oncogene Proteins c-jun, Genes, jun, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review